Phaedra Chrousos is of Vanda Pharmaceuticals Inc.. Currently has a direct ownership of 123,350 shares of VNDA, which is worth approximately $556,308. The most recent transaction as insider was on Jun 05, 2025, when has been sold 59,225 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 123K
92.36% 3M change
92.36% 12M change
Total Value Held $556,308

Phaedra Chrousos Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2025
BUY
Grant, award, or other acquisition
-
59,225 Added 32.44%
123,350 Common Stock
May 22 2024
BUY
Grant, award, or other acquisition
-
21,887 Added 25.45%
64,125 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
17,307 Added 29.07%
42,238 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
12,006 Added 32.5%
24,931 Common Stock
Jun 14 2021
SELL
Open market or private sale
$40,131 $19.34 p/Share
2,075 Reduced 13.83%
12,925 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
5,000 Added 25.0%
15,000 Common Stock
PC

Phaedra Chrousos

Washington, DC

Track Institutional and Insider Activities on VNDA

Follow Vanda Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VNDA shares.

Notify only if

Insider Trading

Get notified when an Vanda Pharmaceuticals Inc. insider buys or sells VNDA shares.

Notify only if

News

Receive news related to Vanda Pharmaceuticals Inc.

Track Activities on VNDA